Read More Pharma Industry News Levo gets FDA fast track status for LV-101 in Prader-Willi syndrome US biotech company Levo Therapeutics has been granted fast track designation for LV-101 (intranasal carbetocin) from the US… bypharmanewsdailyNovember 19, 2019
